MedPath

The effect of exercise on function and concentrations of a single dose of unfractionated hepari

Phase 1
Conditions
nfractionated heparin is used for the prevention and treatment of deep vein thrombosis and complications hereof
Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Registration Number
EUCTR2023-000150-20-DK
Lead Sponsor
Bispebjerg-Frederiksberg Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
15
Inclusion Criteria

•Male between 18 and 50 years old
•Body weight 50 kg or more
•Body Mass Index 18.5-25 kg/m2
•Acceptance of not drinking alcohol for 24 hours before to 24 hours after dosing of study drug
•Acceptance of not performing physical activity for 24 hours before to 24 hours after dosing of study drug
•Signed informed consent form

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 15
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

•History or sign of bleeding disorders
•History or sign of kidney disease
•History or sign of liver disease
•Average systolic blood pressure <100 mmHg or >140 mmHg and/or average diastolic blood pressure <60 mmHg or >90 mmHg (average of three measurements performed at screening).
•Daily pharmaceutical treatment
•Contraindication to increased levels of physical activity (10)
•Smoking or other regular use of any form of nicotine products during the study period and the previous 3 months.
•Current or prior participation (within 3 months before screening) in other clinical trials that might affect the results of this study (judged by the investigator).
•Previous treatment with heparins
•Low levels of anti-thrombin (P-antitrombin(enz.) <0,80 kIU/L)

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath